Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Caplin Point Laboratories Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 16,889.8 Cr.
Price in snapshot: ₹ 2,222
ROE: 20.9 %
ROCE: 21.34 %
Dividend Yield: 0.19 %

Snapshot updated 18 October 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 19 August 2026.
Annual-report coverage: FY2025.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings